Transplant Genomics, Inc.
Clinical trials sponsored by Transplant Genomics, Inc., explained in plain language.
-
New blood test aims to stop viruses after kidney transplants
Knowledge-focused Not yet recruitingThis study will follow 1000 kidney transplant patients for 12 months to see if a new blood test called T-ID can predict and prevent two serious viral infections: CMV disease and BK virus kidney damage. The test measures virus levels and the body's immune strength. The goal is to …
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Blood test may spare kidney patients painful biopsies
Knowledge-focused Not yet recruitingThis study watches 600 kidney transplant patients to see if a blood test (TruGraf/TRAC) can safely track organ health and guide medication. Participants give blood samples over 24 months, and doctors check for rejection, kidney function drops, or other issues. The goal is to lear…
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC